[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2018-2023 Global Phenylketonuria Treatment Market Report (Status and Outlook)

August 2018 | 119 pages | ID: 22BF56A0A63EN
LP Information

US$ 4,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Phenylketonuria Treatment market for 2018-2023.

Phenylketonuria is an inborn error of metabolism that results in decreased metabolism of the amino acid phenylalanine.
The key factor contributing to the phenylketonuria treatment market is the increasing incidence of phenylketonuria.
Over the next five years, LPI(LP Information) projects that Phenylketonuria Treatment will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares and growth opportunities of Phenylketonuria Treatment market by product type, application, key companies and key regions.

To calculate the market size, LP Information considers value generated from the sales of the following segments:

Segmentation by product type:
  • Drugs
  • Dietary Supplement
Segmentation by application:
  • Hospital Pharmacies
  • Drug Stores
  • Online Pharmacies
  • Pediatric Clinics
We can also provide the customized separate regional or country-level reports, for the following regions:
  • Americas
  • United States
  • Canada
  • Mexico
  • Brazil
  • APAC
  • China
  • Japan
  • Korea
  • Southeast Asia
  • India
  • Australia
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
  • Spain
  • Middle East & Africa
  • Egypt
  • South Africa
  • Israel
  • Turkey
  • GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:
  • American Gene Technologies
  • Dimension Therapeutics
  • BioMarin Pharmaceutical
  • Synthetic Biologics
  • Codexis
  • SOM Innovation Biotech
  • Daiichi Sankyo
  • Erytech Pharma
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
  • To study and analyze the global Phenylketonuria Treatment market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
  • To understand the structure of Phenylketonuria Treatment market by identifying its various subsegments.
  • Focuses on the key global Phenylketonuria Treatment players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
  • To analyze the Phenylketonuria Treatment with respect to individual growth trends, future prospects, and their contribution to the total market.
  • To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
  • To project the size of Phenylketonuria Treatment submarkets, with respect to key regions (along with their respective key countries).
  • To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
  • To strategically profile the key players and comprehensively analyze their growth strategies.
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Phenylketonuria Treatment Market Size 2013-2023
  2.1.2 Phenylketonuria Treatment Market Size CAGR by Region
2.2 Phenylketonuria Treatment Segment by Type
  2.2.1 Drugs
  2.2.2 Dietary Supplement
2.3 Phenylketonuria Treatment Market Size by Type
  2.3.1 Global Phenylketonuria Treatment Market Size Market Share by Type (2013-2018)
  2.3.2 Global Phenylketonuria Treatment Market Size Growth Rate by Type (2013-2018)
2.4 Phenylketonuria Treatment Segment by Application
  2.4.1 Hospital Pharmacies
  2.4.2 Drug Stores
  2.4.3 Online Pharmacies
  2.4.4 Pediatric Clinics
2.5 Phenylketonuria Treatment Market Size by Application
  2.5.1 Global Phenylketonuria Treatment Market Size Market Share by Application (2013-2018)
  2.5.2 Global Phenylketonuria Treatment Market Size Growth Rate by Application (2013-2018)

3 GLOBAL PHENYLKETONURIA TREATMENT BY PLAYERS

3.1 Global Phenylketonuria Treatment Market Size Market Share by Players
  3.1.1 Global Phenylketonuria Treatment Market Size by Players (2016-2018)
  3.1.2 Global Phenylketonuria Treatment Market Size Market Share by Players (2016-2018)
3.2 Global Phenylketonuria Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 PHENYLKETONURIA TREATMENT BY REGIONS

4.1 Phenylketonuria Treatment Market Size by Regions
4.2 Americas Phenylketonuria Treatment Market Size Growth
4.3 APAC Phenylketonuria Treatment Market Size Growth
4.4 Europe Phenylketonuria Treatment Market Size Growth
4.5 Middle East & Africa Phenylketonuria Treatment Market Size Growth

5 AMERICAS

5.1 Americas Phenylketonuria Treatment Market Size by Countries
5.2 Americas Phenylketonuria Treatment Market Size by Type
5.3 Americas Phenylketonuria Treatment Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Phenylketonuria Treatment Market Size by Countries
6.2 APAC Phenylketonuria Treatment Market Size by Type
6.3 APAC Phenylketonuria Treatment Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Phenylketonuria Treatment by Countries
7.2 Europe Phenylketonuria Treatment Market Size by Type
7.3 Europe Phenylketonuria Treatment Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Phenylketonuria Treatment by Countries
8.2 Middle East & Africa Phenylketonuria Treatment Market Size by Type
8.3 Middle East & Africa Phenylketonuria Treatment Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 GLOBAL PHENYLKETONURIA TREATMENT MARKET FORECAST

10.1 Global Phenylketonuria Treatment Market Size Forecast (2018-2023)
10.2 Global Phenylketonuria Treatment Forecast by Regions
  10.2.1 Global Phenylketonuria Treatment Forecast by Regions (2018-2023)
  10.2.2 Americas Market Forecast
  10.2.3 APAC Market Forecast
  10.2.4 Europe Market Forecast
  10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
  10.3.1 United States Market Forecast
  10.3.2 Canada Market Forecast
  10.3.3 Mexico Market Forecast
  10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
  10.4.1 China Market Forecast
  10.4.2 Japan Market Forecast
  10.4.3 Korea Market Forecast
  10.4.4 Southeast Asia Market Forecast
  10.4.5 India Market Forecast
  10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
  10.5.1 Germany Market Forecast
  10.5.2 France Market Forecast
  10.5.3 UK Market Forecast
  10.5.4 Italy Market Forecast
  10.5.5 Russia Market Forecast
  10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
  10.6.1 Egypt Market Forecast
  10.6.2 South Africa Market Forecast
  10.6.3 Israel Market Forecast
  10.6.4 Turkey Market Forecast
  10.6.5 GCC Countries Market Forecast
10.7 Global Phenylketonuria Treatment Forecast by Type
10.8 Global Phenylketonuria Treatment Forecast by Application

11 KEY PLAYERS ANALYSIS

11.1 American Gene Technologies
  11.1.1 Company Details
  11.1.2 Phenylketonuria Treatment Product Offered
  11.1.3 American Gene Technologies Phenylketonuria Treatment Revenue, Gross Margin and Market Share (2016-2018)
  11.1.4 Main Business Overview
  11.1.5 American Gene Technologies News
11.2 Dimension Therapeutics
  11.2.1 Company Details
  11.2.2 Phenylketonuria Treatment Product Offered
  11.2.3 Dimension Therapeutics Phenylketonuria Treatment Revenue, Gross Margin and Market Share (2016-2018)
  11.2.4 Main Business Overview
  11.2.5 Dimension Therapeutics News
11.3 BioMarin Pharmaceutical
  11.3.1 Company Details
  11.3.2 Phenylketonuria Treatment Product Offered
  11.3.3 BioMarin Pharmaceutical Phenylketonuria Treatment Revenue, Gross Margin and Market Share (2016-2018)
  11.3.4 Main Business Overview
  11.3.5 BioMarin Pharmaceutical News
11.4 Synthetic Biologics
  11.4.1 Company Details
  11.4.2 Phenylketonuria Treatment Product Offered
  11.4.3 Synthetic Biologics Phenylketonuria Treatment Revenue, Gross Margin and Market Share (2016-2018)
  11.4.4 Main Business Overview
  11.4.5 Synthetic Biologics News
11.5 Codexis
  11.5.1 Company Details
  11.5.2 Phenylketonuria Treatment Product Offered
  11.5.3 Codexis Phenylketonuria Treatment Revenue, Gross Margin and Market Share (2016-2018)
  11.5.4 Main Business Overview
  11.5.5 Codexis News
11.6 SOM Innovation Biotech
  11.6.1 Company Details
  11.6.2 Phenylketonuria Treatment Product Offered
  11.6.3 SOM Innovation Biotech Phenylketonuria Treatment Revenue, Gross Margin and Market Share (2016-2018)
  11.6.4 Main Business Overview
  11.6.5 SOM Innovation Biotech News
11.7 Daiichi Sankyo
  11.7.1 Company Details
  11.7.2 Phenylketonuria Treatment Product Offered
  11.7.3 Daiichi Sankyo Phenylketonuria Treatment Revenue, Gross Margin and Market Share (2016-2018)
  11.7.4 Main Business Overview
  11.7.5 Daiichi Sankyo News
11.8 Erytech Pharma
  11.8.1 Company Details
  11.8.2 Phenylketonuria Treatment Product Offered
  11.8.3 Erytech Pharma Phenylketonuria Treatment Revenue, Gross Margin and Market Share (2016-2018)
  11.8.4 Main Business Overview
  11.8.5 Erytech Pharma News

12 RESEARCH FINDINGS AND CONCLUSION

LIST OF TABLES AND FIGURES

Table Product Specifications of Phenylketonuria Treatment
Figure Phenylketonuria Treatment Report Years Considered
Figure Market Research Methodology
Figure Global Phenylketonuria Treatment Marke


More Publications